Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Pre-Tax Margin
144.43%
Quarterly · Period ending:
LCTX Pre-Tax Margin
Latest reported144.43%period ending
Latest reported144.43%period ending
LCTX Quarterly Pre-Tax Margin (0.00% → 144.43%)
Quarterly pre-tax margin
High-resolution chart · PNG
LCTX pre-tax margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Pre-Tax Margin |
|---|---|
| 0% | |
| 0% | |
| 7,715.5017% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -1,100% | |
| -150% | |
| -1,100% | |
| -140% | |
| -1,000% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -500% | |
| -300% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |